study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
SLP-INOS-OCULAR_01,2005,randomized controlled trial,SMD,-0.3190,-0.4491,-0.1888,50,48,low,10.1080/14767058.2020.1818225,sleep_journal,sleep_latency,Adults with sleep latency concerns,None reported,9
SLP-INOS-OCULAR_02,2006,randomized controlled trial,SMD,-0.3663,-0.5290,-0.2037,54,51,some concerns,10.1159/000478861,sleep_journal,sleep_latency,Adults with sleep latency concerns,Mild GI discomfort,10
SLP-INOS-OCULAR_03,2007,randomized controlled trial,SMD,-0.3924,-0.5263,-0.2585,58,54,mixed,10.3389/fnins.2017.00336,sleep_journal,sleep_latency,Adults with sleep latency concerns,Transient headache,11
